SN Nuclearelectrica SA and Framatome have announced the signing of a cooperation agreement to explore the possibility of producing the medical isotope Lutetium – 177 in the Cernavoda nuclear-electrical unit. Lutetium – 177 is used for a variety of treatment for cancer.According to a press release of SN Nuclearelectrica, the initial domain of implementation of the agreement includes a technical feasibility study, based on the Framatome production technology for isotopes, successfully implemented in Canada in 2022.Framatome and Nuclearelectrica will work together to analyse how to maximize the existing infrastructure in Cernavoda in order to produce medical isotopes, besides the clean, safe, reliable, carbon emissions-free energy generated at present.‘In the light of recent evolutions on the market of medical isotopes, the need for safe supply with medical isotopes is growing and, as a result, we consider that this is the right moment to develop projects of medical isotopes production at CNE Cernavoda’ said Cosmin Ghita, CEO Nuclearelectrica.In his turn, Francois Gauche, the manager of Framatome Healthcare stated: ‘We are delighted to have this project with Nuclearelectrica. Mass access to nuclear medicine is closely connected to the development of supply chains on a large scale, reliable and diversified and we want to play a role in the fight against cancer, by helping to the construction of these supply chains. In order to better help the patients in the future, we will need regional nuclear medicine production centres and this project is an excellent opportunity to consolidate the supply chain in Europe’.Nuclearelectrica has 27 years of experience in safe exploitation of the nuclear-electrical unit in CNE Cernavoda, being considered one of the most performing companies in the domain, at global level. Through strategic investment projects (Retechnologisation of Unit1 CNE Cernavoda, development of Unit 3 and 4 CNE Cernavoda, development of SMR project, development of Detritiation Facility) the company wants to supply clean energy, to support the objectives of energy stability and decarbonisation of Romania, to support the Paris Agreement and on the basis of ESG strategy to support the initiatives with impact on human health, similar to this agreement.Framatome Healthcare commits to develop products and services for the health industry. The team supports the value chain of the radioisotopes used in the radiopharmaceuticals for diagnostic imaging and for therapeutical purposes, supplies advanced solutions for complex installations for sterilization, essential for the use of medical materials. The Framatome Healthcare experts promote fight against cancer, develop and support medical apps of the nuclear technology.
The Board of Directors convenes the Ordinary General Meeting of Shareholders on December 18/19, 2025 The Board of Directors of EVERGENT Investments, an investment company listed under the ticker EVER, has convened the Ordinary General Meeting of Shareholders for December 18/19, 2025. The proposal submitted for shareholders’ approval is the distribution of dividends from reserves […]
City Grill Group surpasses EUR 63.5 million in revenue in the first 10 months With one in six people affected by loneliness, according to the WHO, restaurants are once again becoming essential spaces for reconnection, and dining out is reclaiming its role as an authentic social experience. City Grill Group, the largest Romanian-owned restaurant chain, […]
The Apple Sports app, which provides real-time information and results from multiple sports, became available in Romania this week following a major European expansion, according to the company. The US smartphone maker made the app available in 20 European countries, including Romania. Now available in the App Store on the company’s devices, the Apple Sports...
An exhibition dedicated to the work of William Blake will open at the “Alexandru and Aristia Aman” Dolj County Library in Craiova between November 28 and December 12. Titled William Blake’s Painting in the Light of Sahaja Yoga, the photo-documentary display is curated by Carol and Luis Garrido (UK), whose 14 years of research led […]
The Bucharest Stock Exchange (BVB) kicked off a series of week-long events on Monday, November 17, to mark its 30th anniversary. Brokers, investors, and regulators discussed the evolution of Romanian equities, investment funds, and financial education. They stressed that the local stock market has offered higher returns than other types of investments. The first day […]
AROBS Transilvania Software (BVB: AROBS), a leading entrepreneurial technology company listed on the Bucharest Stock Exchange (BVB), recorded consolidated revenues of RON 328 million in the first nine months of 2025, up 7% compared to the same period last year. According to the company’s report, EBITDA also reached RON 50 million, a 15% increase, while […]
